Researchers Mass Produce Reprogrammed T Cells That Target Cancer Cells, Memorial Sloan-Kettering Cancer Center Study

Published: Aug 12, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

A team of researchers at the Memorial Sloan-Kettering Cancer Center has developed a method for mass producing T cells that have been reprogrammed using stem cell technology to target and destroy cancerous tumors. In their paper published in the journal Nature Biotechnology, the team describes how they collected isolated T cells, reprogrammed them into stem cells, added a gene marker, than reprogrammed them back into T cells that are able to target cells in cancerous tumors.

Hey, check out all the research scientist jobs. Post your resume today!

Back to news